Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Mahmood Ahmed
Mahmood Ahmed, Harlow GB
| Patent application number | Description | Published |
|---|---|---|
| 20090036682 | Quinoline Derivatives and Their Use as 5-HT6 Ligands - The present invention relates to novel quinoline compounds having pharmacological activity, to processes for their preparation, to compositions containing them and to their use in the treatment of CNS and other disorders. | 02-05-2009 |
| 20100305107 | QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS - Disclosed are quinoline compounds having affinity for the 5-HT | 12-02-2010 |
Mahmood Ahmed, Singapore SG
| Patent application number | Description | Published |
|---|---|---|
| 20100048639 | OXADIAZOLE DERIVATES AS S1P1 RECEPTOR AGONISTS - The present invention relates to novel oxadiazole compounds of formula (I) | 02-25-2010 |
| 20100113528 | OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE (S1P) AGONISTS - The present invention provides compounds of formula (I) or salts thereof: | 05-06-2010 |
| 20100113796 | INDOLE DERIVATIVES AS S1P1 RECEPTOR - The invention relates to compounds of formula (I) | 05-06-2010 |
Mahmood Ahmed, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20080318933 | 5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders - The present invention relates to novel indole derivatives such as compounds of the formula (I): | 12-25-2008 |
| 20090012056 | Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor - The present invention relates to novel quinoline derivatives such as compounds of the formula (I) which possess antagonist potency for the 5-HT | 01-08-2009 |
| 20090298841 | QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS - The present invention relates to novel quinoline compounds having pharmacological activity, to processes for their preparation, to compositions containing them and to their use in the treatment of CNS and other disorders. | 12-03-2009 |